ResearcherInsermNo recent work listed

V’yacheslav Lehen’kyi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0806-8766; OpenAlex author ID A5036612570. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Last author DOI 10.3390/cancers15245769 ↗
Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. Last author DOI 10.3390/cells10051021 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gonçalo Mesquita · 2 shared papers, 2021–2023 · strength 0.36
- Paper Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. DOI 10.3390/cells10051021 ↗
- Paper TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. DOI 10.3390/cancers15245769 ↗
Albrecht Schwab · 2 shared papers, 2021–2023 · strength 0.36
- Paper Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. DOI 10.3390/cells10051021 ↗
- Paper TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. DOI 10.3390/cancers15245769 ↗
Natalia B. Prevarskaya · 2 shared papers, 2021–2023 · strength 0.36
- Paper Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. DOI 10.3390/cells10051021 ↗
- Paper TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. DOI 10.3390/cancers15245769 ↗
Zoltán Pethő · 1 shared paper, 2023 · strength 0.17
- Paper TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. DOI 10.3390/cancers15245769 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.